Alimentiv Translational Research Consortium Symposium

IL-23 Pathway Inhibition in IBD

Register Today

When

May 6, 2021 @ 9:00 am - 12:30 pm EDT, and May 7, 2021 @ 9:00 am - 12:30 pm EDT

Watch presentations by our expert presenters and join interactive working sessions.

IL-23 Pathway Inhibition In IBD

This two-half day, virtual educational event is organized for and by members of the Alimentiv Translational Research Consortium to understand the role of IL-23 pathway inhibition in IBD. The Symposium will bring together key stakeholders including gastroenterologists, basic & translational scientists, clinical pharmacologists, trialists and industry sponsors.

Expert Panel

Markus Neurath, MD

Friedrich-Alexander-Universität (FAU), Erlangen-Nürnberg, Germany

Bruce Sands, MD

Mount Sinai, NY, USA

Brian Feagan, MD

Alimentiv Inc., Canada

Wouter de Jonge, PhD

Amsterdam UMC, Netherlands

Clara Abraham, MD

Yale, USA

Harry Sokol, MD, PhD

Sorbonne University, Inserm, France

Joseph Adedokun, MS, RPh

Johnson & Johnson, USA

Lili Cheng, PhD

Protagonist, USA

Maria Abreu, MD

University of Miami, USA

Agenda At A Glance

Agenda for May 6, 2021 (Virtual)

Day 1

Agenda for May 7, 2021 (Virtual)

Day 2

Download full agenda